A Randomized, Double Blind, Placebo Controlled Phase 2 Study To assess the Immune Response Following Administration of Influenza and Pneumococcal Vaccines to Subjects with Rheumatoid Arthritis receiving CP-690,550 with and Without background Methotrexate
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01359150?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
